Nordic Life Science 1
Pioneering dose accuracy Enabling adjustable dosa
ge forms Reduced environmental footprint Enhanced working environment Advancing the Next Generation of Personalized Medicines As Sweden’s leading manufacturer of extemporaneous medicines, APL is proud to introduce a new era of pharmaceutical innovation. By investing in advanced 3D printing technology, we are redefining the possibilities of extemporaneous manufacturing and offering significant advantages in patient safety, product precision, and environmental sustainability. With a continuous presence in the healthcare market, APL rapidly identifies emerging needs and responds with agility when new treatment solutions are required. Our latest innovation, ExtempoPrint®, empowers us to deliver truly personalized medicines with even greater efficiency and accuracy. If you’re interested in learning how we can support your clinical development, visit us at booth no. B06:19 at NLS Days in October 2025. For more information: apl.se/ExtempoPrint